Ashleigh Kernohan

1.5k total citations · 2 hit papers
45 papers, 875 citations indexed

About

Ashleigh Kernohan is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Genetics. According to data from OpenAlex, Ashleigh Kernohan has authored 45 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Ophthalmology and 14 papers in Genetics. Recurrent topics in Ashleigh Kernohan's work include Glioma Diagnosis and Treatment (14 papers), Retinal Diseases and Treatments (12 papers) and Ophthalmology and Visual Impairment Studies (8 papers). Ashleigh Kernohan is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Retinal Diseases and Treatments (12 papers) and Ophthalmology and Visual Impairment Studies (8 papers). Ashleigh Kernohan collaborates with scholars based in United Kingdom, Australia and Italy. Ashleigh Kernohan's co-authors include Siv Mørkved, June D Cody, Stephanie J. Woodley, Jean Hay‐Smith, Peter R. Lawrenson, Theresa A Lawrie, Luke Vale, Robin Grant, Jonathan J. Evans and David Gillespie and has published in prestigious journals such as Stroke, Cochrane Database of Systematic Reviews and BMJ.

In The Last Decade

Ashleigh Kernohan

43 papers receiving 859 citations

Hit Papers

Pelvic floor muscle training for preventing and treating ... 2020 2026 2022 2024 2020 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashleigh Kernohan United Kingdom 16 290 256 213 183 173 45 875
Min Joung Lee South Korea 18 234 0.8× 214 0.8× 390 1.8× 104 0.6× 83 0.5× 95 1.3k
Jade S. Schiffman United States 23 243 0.8× 152 0.6× 618 2.9× 141 0.8× 57 0.3× 63 1.7k
Raffaella Fazio Italy 24 103 0.4× 309 1.2× 61 0.3× 124 0.7× 136 0.8× 66 1.7k
Ali S. Haider United States 15 168 0.6× 100 0.4× 61 0.3× 89 0.5× 189 1.1× 102 807
Paul E. Kim United States 16 128 0.4× 228 0.9× 31 0.1× 78 0.4× 161 0.9× 44 866
Kathleen J. Helton United States 27 173 0.6× 225 0.9× 86 0.4× 76 0.4× 1.1k 6.4× 62 1.8k
Scott E. Olitsky United States 18 138 0.5× 124 0.5× 388 1.8× 20 0.1× 197 1.1× 69 975
Jae Ho Kim United States 13 142 0.5× 257 1.0× 165 0.8× 28 0.2× 188 1.1× 31 810
Craig N. Czyz United States 18 141 0.5× 241 0.9× 558 2.6× 25 0.1× 67 0.4× 73 1.2k
Gazanfer Ekinci Türkiye 18 144 0.5× 112 0.4× 34 0.2× 66 0.4× 120 0.7× 66 847

Countries citing papers authored by Ashleigh Kernohan

Since Specialization
Citations

This map shows the geographic impact of Ashleigh Kernohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh Kernohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh Kernohan more than expected).

Fields of papers citing papers by Ashleigh Kernohan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashleigh Kernohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh Kernohan. The network helps show where Ashleigh Kernohan may publish in the future.

Co-authorship network of co-authors of Ashleigh Kernohan

This figure shows the co-authorship network connecting the top 25 collaborators of Ashleigh Kernohan. A scholar is included among the top collaborators of Ashleigh Kernohan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashleigh Kernohan. Ashleigh Kernohan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lawrenson, John G, Byki Huntjens, Gianni Virgili, et al.. (2025). Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database of Systematic Reviews. 2025(2). CD014758–CD014758. 3 indexed citations
3.
Shabaninejad, Hosein, Tara Homer, Ashleigh Kernohan, et al.. (2024). Is primary trabeculectomy cost-effective for patients with advanced primary open angle glaucoma? Results from the Treatment of Advanced Glaucoma Study economic model. British Journal of Ophthalmology. 108(9). 1210–1215.
4.
Robinson, Tomos, et al.. (2024). Valuing selected WAItE health states using the Time Trade-Off methodology: findings from an online interviewer-assisted remote survey. Journal of Patient-Reported Outcomes. 8(1). 6–6. 2 indexed citations
5.
Coughlan, Diarmuid, Katie Thomson, Ge Yu, et al.. (2023). Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective. PharmacoEconomics. 42(1). 5–9. 1 indexed citations
7.
Rodgers, Jacqui, Jane Goodwin, Deborah Garland, et al.. (2022). Coping with uncertainty in everyday situations (CUES©) to address intolerance of uncertainty in autistic children: an intervention feasibility trial. Journal of Autism and Developmental Disorders. 53(9). 3460–3474. 17 indexed citations
8.
Kernohan, Ashleigh, Tara Homer, Hosein Shabaninejad, et al.. (2022). Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma. British Journal of Ophthalmology. 107(10). 1452–1457. 2 indexed citations
10.
Baker, Katherine, Gill Barry, Chris Harding, et al.. (2022). Acupuncture for treating overactive bladder in adults. Cochrane Database of Systematic Reviews. 2022(9). CD013519–CD013519. 12 indexed citations
11.
Brandner, Sebastian, Alexandra McAleenan, Hayley E Jones, et al.. (2021). Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review. Neuropathology and Applied Neurobiology. 48(4). e12790–e12790. 18 indexed citations
12.
King, Anthony, Jemma Hudson, Gordon Fernie, et al.. (2021). Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS). BMJ. 373. n1014–n1014. 40 indexed citations
13.
King, Anthony, Gordon Fernie, Jemma Hudson, et al.. (2021). Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT. Health Technology Assessment. 25(72). 1–158. 11 indexed citations
15.
Suklan, Jana, James Cheaveau, Sarah Hill, et al.. (2021). Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis. Viruses. 13(5). 803–803. 4 indexed citations
16.
King, Anthony, Jemma Hudson, Gordon Fernie, et al.. (2020). Baseline Characteristics of Participants in the Treatment of Advanced Glaucoma Study: A Multicenter Randomized Controlled Trial. American Journal of Ophthalmology. 213. 186–194. 7 indexed citations
17.
Hanna, Catherine, Theresa A Lawrie, Ewelina Rogozińska, et al.. (2020). Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database of Systematic Reviews. 2020(3). CD013261–CD013261. 49 indexed citations
18.
Grant, Robin, Therese Dowswell, E. Tomlinson, et al.. (2020). Interventions to reduce the time to diagnosis of brain tumours. Cochrane Database of Systematic Reviews. 2020(9). CD013564–CD013564. 6 indexed citations
19.
20.
Lake, Jonathan, et al.. (2019). Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification. Cochrane Database of Systematic Reviews. 2019(12). CD012801–CD012801. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026